Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation

The cardiac glycoside digoxin was identified as a potent suppressor of pyruvate kinase isoform 2-hypoxia-inducible factor-α (PKM2-HIF-1α) pathway activation in liver injury mouse models via intraperitoneal injection. We have assessed the therapeutic effects of digoxin to reduce nonalcoholic steatohe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Physiol Gastrointest Liver Physiol
Main Authors: Zhao, Peng, Han, Sheng-Na, Arumugam, Suyavaran, Yousaf, Muhammad Nadeem, Qin, Yanqin, Jiang, Joy X., Torok, Natalie Julia, Chen, Yonglin, Mankash, Mohd Salah, Liu, Junbao, Li, Jiansheng, Iwakiri, Yasuko, Ouyang, Xinshou
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842989/
https://ncbi.nlm.nih.gov/pubmed/31411894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpgi.00054.2019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados